{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T21:11:36Z","timestamp":1779311496435,"version":"3.51.4"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,10]],"date-time":"2021-12-10T00:00:00Z","timestamp":1639094400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy Nucleic Acids"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.omtn.2021.12.013","type":"journal-article","created":{"date-parts":[[2021,12,11]],"date-time":"2021-12-11T07:14:21Z","timestamp":1639206861000},"page":"335-348","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Mechanism of action of hepatitis B virus S antigen transport-inhibiting oligonucleotide polymer, STOPS, molecules"],"prefix":"10.1016","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6958-8784","authenticated-orcid":false,"given":"C. Cheng","family":"Kao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuchun","family":"Nie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suping","family":"Ren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N. Tilani T.S.","family":"De Costa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajendra K.","family":"Pandey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin","family":"Hong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David B.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julian A.","family":"Symons","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leonid","family":"Beigelman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lawrence M.","family":"Blatt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.omtn.2021.12.013_bib1","series-title":"Global Progress Report on HIV, Viral Hepatitis and Sexually Transmitted Infections","year":"2021"},{"key":"10.1016\/j.omtn.2021.12.013_bib2","first-page":"548","article-title":"Chronic hepatitis B infection, a review. JAMA 319:1802-1813.6. Yip TC, Lok AS. 2020. How do we determine whether a functional cure of HBV infection has been achieved?","volume":"18","author":"Tang","year":"2018","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"10.1016\/j.omtn.2021.12.013_bib3","doi-asserted-by":"crossref","first-page":"95","DOI":"10.3390\/v9050095","article-title":"Interplay between the hepatitis B virus and innate immunity: from an understanding to the development of therapeutic concepts","volume":"9","author":"Faure-Dupuy","year":"2017","journal-title":"Viruses"},{"key":"10.1016\/j.omtn.2021.12.013_bib4","doi-asserted-by":"crossref","first-page":"a021428","DOI":"10.1101\/cshperspect.a021428","article-title":"Immune response in hepatitis B virus infection","volume":"5","author":"Tan","year":"2015","journal-title":"Cold Spring Harb Perspect. Med."},{"key":"10.1016\/j.omtn.2021.12.013_bib5","first-page":"439","article-title":"Emerging therapies toward a functional cure for hepatitis B virus infection","volume":"14","author":"Kim","year":"2018","journal-title":"Gastroenterol. Hepatol."},{"key":"10.1016\/j.omtn.2021.12.013_bib6","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1002\/hep.28025","article-title":"Present and future therapies of hepatitis B: from discovery to cure","volume":"62","author":"Liang","year":"2015","journal-title":"Hepatol."},{"key":"10.1016\/j.omtn.2021.12.013_bib7","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.jhep.2004.10.026","article-title":"Long-term clinical and histological outcomes in patients with spontaneous hepatitis B surface antigen seroclearance","volume":"42","author":"Ahn","year":"2005","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.omtn.2021.12.013_bib8","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.cgh.2019.07.018","article-title":"Durability of spontaneous and treatment-related loss of hepatitis B S-antigen","volume":"18","author":"Alawad","year":"2020","journal-title":"Clin. Gastroenterol Hepatol."},{"key":"10.1016\/j.omtn.2021.12.013_bib9","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1053\/j.gastro.2008.07.008","article-title":"HBsAg seroclearance in chronic hepatitis B in Asian patients: replicative level and risk of hepatocellular carcinoma","volume":"135","author":"Yuen","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.omtn.2021.12.013_bib10","doi-asserted-by":"crossref","unstructured":"Tout I., Loureiro D., Mansour A., Soumelis V., Boyer N., and Asselah T. Hepatitis B surface antigen seroclearance: immune mechanisms, clinical impact, importance for drug development. J. Hepatol. 73: 409-422.","DOI":"10.1016\/j.jhep.2020.04.013"},{"key":"10.1016\/j.omtn.2021.12.013_bib11","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.jhep.2018.10.014","article-title":"HBsAg seroclearance further reduces hepatocellular carcinoma risk after complete viral suppression with nucleos(t)ide analogues","volume":"70","author":"Yip","year":"2019","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.omtn.2021.12.013_bib12","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/S2468-1253(19)30190-6","article-title":"Targets and future direct-acting antiviral approaches to achieve hepatitis B virus cure","volume":"4","author":"Asselah","year":"2019","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"10.1016\/j.omtn.2021.12.013_bib13","doi-asserted-by":"crossref","first-page":"5291","DOI":"10.1128\/AAC.01003-13","article-title":"Nucleic acid polymers inhibit duck hepatitis B virus infection in\u00a0vitro","volume":"57","author":"Noordeen","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.omtn.2021.12.013_bib14","doi-asserted-by":"crossref","first-page":"5299","DOI":"10.1128\/AAC.01005-13","article-title":"Nucleic acid polymers prevent the establishment of duck hepatitis B virus infection in\u00a0vivo","volume":"57","author":"Noordeen","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.omtn.2021.12.013_bib15","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1002\/hep.29737","article-title":"Nucleic acid polymerase REP 2139 and nucleos(T)ide analogues act synergistically against chronic hepadnaviral infection in\u00a0vitro in Pekin ducks","volume":"67","author":"Quinet","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.omtn.2021.12.013_bib16","doi-asserted-by":"crossref","first-page":"e0156667","DOI":"10.1371\/journal.pone.0156667","article-title":"Safety and efficacy of nucleic acid polymers in monotherapy and combined with immunotherapy in treatment-na\u00efve Bangladeshi patients with HBeAg+ chronic hepatitis B infection","volume":"11","author":"Al-Mahtab","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.omtn.2021.12.013_bib17","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/S2468-1253(17)30288-1","article-title":"Safety and efficacy of REP 2130 and pegylated interferon alfa-2a for treatment-na\u00efve patients with chronic hepatitis B virus and hepatitis D virus co-infection (REP 301 and REP 301-LTF): a non-randomised, open-label, phase 2 trial","volume":"2","author":"Bazinet","year":"2017","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"10.1016\/j.omtn.2021.12.013_bib18","doi-asserted-by":"crossref","first-page":"43838","DOI":"10.1038\/srep43838","article-title":"Nucleic acid-based polymers effective against hepatitis B virus infection in patients don\u2019t harbor immunostimulatory properties in primary isolated liver cells","volume":"7","author":"Real","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.omtn.2021.12.013_bib19","doi-asserted-by":"crossref","first-page":"e01416","DOI":"10.1128\/JVI.01416-17","article-title":"Nucleic acid polymers are active against hepatitis delta virus infection in\u00a0vitro","volume":"92","author":"Beilstein","year":"2018","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.omtn.2021.12.013_bib20","doi-asserted-by":"crossref","first-page":"S876","DOI":"10.1016\/S0168-8278(20)32194-2","article-title":"Structural requirements for S-antigen transport-inhibiting oligonucleotide polymer inhibition of hepatitis B surface antigen secretion","volume":"73","author":"Fitzgerald","year":"2020","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.omtn.2021.12.013_bib21","doi-asserted-by":"crossref","first-page":"104853","DOI":"10.1016\/j.antiviral.2020.104853","article-title":"Characterization of the antiviral effects of REP 2139 on the HBV lifecycle in\u00a0vitro","volume":"183","author":"Boulon","year":"2020","journal-title":"Antiviral Res"},{"key":"10.1016\/j.omtn.2021.12.013_bib22","doi-asserted-by":"crossref","first-page":"9872","DOI":"10.1093\/nar\/gkaa717","article-title":"Ribosomal stalk proteins RPLP1 and RPLP2 promote biogenesis of flaviviral and cellular multi-pass transmembrane proteins","volume":"48","author":"Campos","year":"2020","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omtn.2021.12.013_bib23","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1089\/ars.2009.2485","article-title":"Role of the unfolded protein response regulator GRP78\/BiP in development, cancer, and neurological disorders","volume":"11","author":"Wang","year":"2009","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.omtn.2021.12.013_bib24","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1038\/s41467-017-02770-z","article-title":"Molecular basis for the specific and multivariant recognitions of RNA substrates by human hnRNPA2B1","volume":"9","author":"Wu","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omtn.2021.12.013_bib25","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1158\/1541-7786.MCR-14-0131","article-title":"Emerging functions of SRSF1, splicing protein and oncoprotein, in RNA metabolism and cancer","volume":"12","author":"Das","year":"2014","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.omtn.2021.12.013_bib26","doi-asserted-by":"crossref","first-page":"e01706","DOI":"10.1128\/JVI.01706-16","article-title":"RPLP1 and RPLP2 are essential flavivirus host factors that promote early viral protein accumulation","volume":"91","author":"Campos","year":"2017","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.omtn.2021.12.013_bib27","doi-asserted-by":"crossref","first-page":"3851","DOI":"10.1128\/JVI.72.5.3851-3858.1998","article-title":"Involvement of endoplasmic reticulum chaperones in the folding of hepatitis C virus glycoproteins","volume":"72","author":"Choukhi","year":"1998","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.omtn.2021.12.013_bib28","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.02274-16","article-title":"GRP78 is an important host factor for Japanese encephalitis virus replication in mammalian cells","volume":"91","author":"Nain","year":"2017","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.omtn.2021.12.013_bib29","doi-asserted-by":"crossref","first-page":"13812","DOI":"10.1093\/nar\/gku1170","article-title":"HIV-1 transcription is regulated by splicing factor SRSF1","volume":"42","author":"Paz","year":"2014","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omtn.2021.12.013_bib30","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00367-20","article-title":"hnRNPA2B1 associated with recruitment of RNA into exosomes plays a key role in herpes simplex virus 1 release from infected cells","volume":"94","author":"Zhou","year":"2020","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.omtn.2021.12.013_bib31","doi-asserted-by":"crossref","DOI":"10.1017\/S0033583518000100","article-title":"The enigmatic ribosomal stalk","volume":"51","author":"Liljas","year":"2018","journal-title":"Q.\u00a0Rev. Biophys."},{"key":"10.1016\/j.omtn.2021.12.013_bib32","doi-asserted-by":"crossref","first-page":"E2802","DOI":"10.1073\/pnas.1303445110","article-title":"Isolated pseudo-RNA recognition motifs of SR proteins can regulate splicing using a noncanonical mode of RNA recognition","volume":"110","author":"Cl\u00e9ry","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.omtn.2021.12.013_bib33","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1126\/science.aax3769","article-title":"Cellular quality control by the ubiquitin-proteasome system and autophagy","volume":"366","author":"Pohl","year":"2019","journal-title":"Science"},{"key":"10.1016\/j.omtn.2021.12.013_bib34","doi-asserted-by":"crossref","first-page":"2690","DOI":"10.1074\/mcp.M110.003418","article-title":"Identification of essential filovirion-associated host factors by serial proteomic analysis and RNAi screen","volume":"9","author":"Spurger","year":"2010","journal-title":"Mol. Cell Proteomics"},{"key":"10.1016\/j.omtn.2021.12.013_bib35","doi-asserted-by":"crossref","first-page":"7456","DOI":"10.1021\/jacs.9b13524","article-title":"Origins of the increased affinity of phosphorothioate-modified therapeutic nucleic acids for proteins","volume":"142","author":"Hyjek-Skladanowska","year":"2020","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.omtn.2021.12.013_bib36","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1038\/s41467-020-20481-w","article-title":"Structure of SRSF1 RRM1 bound to RNA reveals an unexpected bimodal mode of interaction and explains its involvement in SMN1 exon 7 splicing","volume":"12","author":"Cl\u00e9ry","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omtn.2021.12.013_bib37","doi-asserted-by":"crossref","first-page":"12326","DOI":"10.1093\/nar\/gkaa1085","article-title":"Design and applications of circular RNAs with protein-sponge function","volume":"48","author":"Schreiner","year":"2020","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omtn.2021.12.013_bib38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1074-5521(00)00058-2","article-title":"Locked nucleic acid (LNS): fine-tuning the recognition of DNA and RNA","volume":"8","author":"Braasch","year":"2001","journal-title":"Chem. Biol."},{"key":"10.1016\/j.omtn.2021.12.013_bib39","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1007\/s00439-016-1683-5","article-title":"The hnRNP family: insights into their role in health and disease","volume":"135","author":"Guerens","year":"2016","journal-title":"Hum. Genet."},{"key":"10.1016\/j.omtn.2021.12.013_bib40","doi-asserted-by":"crossref","first-page":"508","DOI":"10.3390\/cells8050508","article-title":"Regulation of ribosomal proteins on viral infection","volume":"8","author":"Li","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.omtn.2021.12.013_bib41","doi-asserted-by":"crossref","first-page":"3029","DOI":"10.1016\/j.febslet.2008.07.039","article-title":"Internal translation initiation on the foot-and-mouth disease virus IRES is affected by ribosomal stalk conformation","volume":"582","author":"Martinez-Azorin","year":"2008","journal-title":"FEBS Lett."},{"key":"10.1016\/j.omtn.2021.12.013_bib42","first-page":"5447","article-title":"Maraviroc: a review of its use in HIV infection and beyond.","volume":"9","author":"Woollard","year":"2015","journal-title":"Drug Des Deval There"},{"key":"10.1016\/j.omtn.2021.12.013_bib43","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1716153","article-title":"Patisiran, and RNAi therapeutic, for hereditary transthyretin amyloidosis","volume":"379","author":"Adams","year":"2018","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.omtn.2021.12.013_bib44","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1358\/dot.2021.57.1.3230207","article-title":"Givosiran to treat porphyria","volume":"57","author":"Honor","year":"2021","journal-title":"Drugs Today"},{"key":"10.1016\/j.omtn.2021.12.013_bib45","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1016\/j.ymthe.2020.06.015","article-title":"Delivery of oligonucleotides to the liver with GalNac: from research to registered therapeutic drugs","volume":"28","author":"Debacker","year":"2020","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtn.2021.12.013_bib46","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.1365-2818.2006.01706.x","article-title":"A guided tour into subcellular colocalization analysis in light microscopy","volume":"224","author":"Bolte","year":"2006","journal-title":"J.\u00a0Microsc."}],"container-title":["Molecular Therapy Nucleic Acids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2162253121003164?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2162253121003164?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T09:56:53Z","timestamp":1750154213000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2162253121003164"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":46,"alternative-id":["S2162253121003164"],"URL":"https:\/\/doi.org\/10.1016\/j.omtn.2021.12.013","relation":{},"ISSN":["2162-2531"],"issn-type":[{"value":"2162-2531","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mechanism of action of hepatitis B virus S antigen transport-inhibiting oligonucleotide polymer, STOPS, molecules","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy Nucleic Acids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omtn.2021.12.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s).","name":"copyright","label":"Copyright"}]}}